Corrections to Identifi cation of children at risk of infl uenza-related complications in primary and ambulatory care: A systematic review and meta-analysis. [Lancet Respir Med (2014), published online Dec 4. DOI: 10.1016/S2213-2600(14)70252-8];Identification of children at risk of influenza-related complications in primary and ambulatory care: A systematic review and meta-analysis

The Lancet Respiratory Medicine

Volumn 3, Issue 2, 2015, Pages 139-149

  Gill, Peter J ^a,b   Ashdown, Helen F ^a   Wang, Kay ^a   Heneghan, Carl ^a   Roberts, Nia W ^c   Harnden, Anthony ^a   Mallett, Susan ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMBULATORY CARE; ARTICLE; ASTHMA; DIABETES MELLITUS; EVIDENCE BASED MEDICINE; FLU LIKE SYNDROME; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INFLUENZA; NEUROLOGIC DISEASE; OBESITY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREMATURITY; PRIMARY MEDICAL CARE; RISK ASSESSMENT; SICKLE CELL ANEMIA; SYSTEMATIC REVIEW; AGE; CHILD; COMORBIDITY; COMPLICATION; INFANT; META ANALYSIS; NEWBORN; PRESCHOOL CHILD; PRIMARY HEALTH CARE; RISK FACTOR;

AGE FACTORS; AMBULATORY CARE; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DIABETES MELLITUS; HUMANS; IMMUNOSUPPRESSION; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFLUENZA, HUMAN; NERVOUS SYSTEM DISEASES; PATIENT ADMISSION; PRIMARY HEALTH CARE; RISK FACTORS;

EID: 84922022198     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(14)70312-1     Document Type: Erratum

References (70)

1. Nair H, Brooks WA, Katz M, et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 2011, 378:1917-1930.
2. Van Kerkhove MD, Vandemaele KA, Shinde V, et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med 2011, 8:e1001053.
3. Belongia EA, Irving SA, Waring SC, et al. Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections. JAMA 2010, 304:1091-1098.
4. Loughlin J, Poulios N, Napalkov P, Wegmuller Y, Monto AS A study of influenza and influenza-related complications among children in a large US health insurance plan database. Pharmacoeconomics 2003, 21:273-283.
5. Irwin DE, Weatherby LB, Huang WY, Rosenberg DM, Cook SF, Walker AM Impact of patient characteristics on the risk of influenza/ILI-related complications. BMC Health Services Research 2001, 1:8.
6. Cromer D, van Hoek AJ, Jitb M, Edmunds WJ, Fleming D, Miller E The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy. J Infect 2014, 68:363-371.
7. Myles PR, Semple MG, Lim WS, et al. Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK. Thorax 2012, 67:709-717.
8. Influenza. Immunisation against infectious disease: the green book 2013, Department of Health, The Stationery Office, London. D. Salisbury, M. Ramsay, K. Noakes (Eds.).
9. Background paper on influenza vaccines and immunization SAGE Working Group 2012, WHO Strategic Advisory Group of Experts on Immunization, World Health Organisation, (accessed Nov 14, 2014). http://www.who.int/immunization/sage/meetings/2012/april/1_Background_Paper_Mar26_v13_cleaned.pdf.
10. Grohskopf LA, Olsen SJ, Sokolow LZ, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2014-15 influenza season. MMWR Recomm Rep 2014, 63:691-697.
11. Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM Antiviral agents for the treatment and chemoprophylaxis of influenza - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011, 60:1-24.
12. Hak E, Verheij TJ, van Essen GA, Lafeber AB, Grobbee DE, Hoes AW Prognostic factors for influenza-associated hospitalization and death during an epidemic. Epidemiol Infect 2001, 126:261-268.
13. Mertz D, Kim TH, Johnstone J, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ 2013, 347:f5061.
14. Wong KK, Jain S, Blanton L, et al. Influenza-associated pediatric deaths in the United States, 2004-2012. Pediatrics 2013, 132:796-804.
15. Morgan OW, Bramley A, Fowlkes A, et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS One 2010, 5:e9694.
16. Marild K, Fredlund H, Ludvigsson JF Increased risk of hospital admission for influenza in patients with celiac disease: a nationwide cohort study in Sweden. Am J Gastroenterol 2010, 105:2465-2473.
17. Boluyt N, Tjosvold L, Lefebvre C, Klassen TP, Offringa M Usefulness of systematic review search strategies in finding child health systematic reviews in MEDLINE. Arch Pediatr Adolesc Med 2008, 162:111-116.
18. Wolff R, Whiting PF, Mallett S, et al. Prediction study risk of bias assessment tool (PROBAST). 21st Cochrane Colloquium; Quebec City, QC Canada; Sept 19-23, 2013. O1.06.
19. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011, 155:529-536.
20. Hayden JA, van der Windt DA, Cartwright JL, Cote P, Bombardier C Assessing bias in studies of prognostic factors. Ann Intern Med 2013, 158:280-286.
21. Mallett S, Royston P, Dutton S, Waters R, Altman DG Reporting methods in studies developing prognostic models in cancer: a review. BMC Med 2010, 8:20.
22. Abo-Zaid G, Guo B, Deeks JJ, et al. Individual participant data meta-analyses should not ignore clustering. J Clin Epidemiol 2013, 66:865-873.
23. Debray TP, Moons KG, Abo-Zaid GM, Koffijberg H, Riley RD Individual participant data meta-analysis for a binary outcome: one-stage or two-stage?. PLoS One 2013, 8:e60650.
24. Bradburn MJ, Deeks JJ, Berlin JA, Russell Localio A Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med 2007, 26:53-77.
25. Greenland S, Salvan A Bias in the one-step method for pooling study results. Stat Med 1990, 9:247-252.
26. Sweeting MJ, Sutton AJ, Lambert PC What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med 2004, 23:1351-1375.
27. Aguirre E, Papenburg J, Ouakki M, et al. Comparison of pandemic and seasonal influenza in the pediatric emergency department. Pediatr Infect Dis J 2011, 30:633-639.
28. Bailhache M, Sarlangue J, Castella C, Richer O, Fleury H, Koeck JL [Influenza A(H1N1)v virus infection in infants less than 6 months of age in southwestern France]. Arch Pediatr 2011, 18:383-389.
29. Bender JM, Ampofo K, Gesteland P, et al. Development and validation of a risk score for predicting hospitalization in children with influenza virus infection. Pediatr Emerg Care 2009, 25:369-375.
30. Bogie AL, Grant K, Hallford G, Anderson M The epidemiology of pediatric patients seen at the Children's Hospital of Oklahoma with laboratory confirmed influenza in 2009. JOkla State Med Assoc 2011, 104:345-351.
31. Carcione D, Giele C, Dowse GK, et al. Comparison of pandemic (H1N1) 2009 and seasonal influenza, Western Australia, 2009. Emerg Infect Dis 2010, 16:1388-1395.
32. Goggin LS, Carcione D, Mak DB, et al. Chronic disease and hospitalisation for pandemic (H1N1) 2009 influenza in Indigenous and non-Indigenous Western Australians. Commun Dis Intell Q Rep 2011, 35:172-176.
33. Crisinel P-A, Barazzone C, Kaiser L, et al. Comparison of clinical presentation of respiratory tract infections in H1N1/09-positive and H1N1/09-negative patients. Eur J Pediatr 2012, 171:159-166.
34. De Marco G, Mangani S, Correra A, et al. Reduction of inappropriate hospital admissions of children with influenza-like illness through the implementation of specific guidelines: a case-controlled study. Pediatrics 2005, 116:e506-e511.
35. Desmoulins C, Michard-Lenoir AP, Naud J, Claudet I, Nouyrigat V, Cheron G Clinical features and outcome of 2009 H1N1 influenza in the pediatric setting. Multicenter prospective study in the ED. Arch Pediatr 2011, 18:505-511.
36. Dubnov-Raz G, Somech R, Warschawski Y, Eisenberg G, Bujanover Y Clinical characteristics of children with 2009 pandemic H1N1 influenza virus infections. Pediatr Int 2011, 53:426-430.
37. Gastanaduy AS, Begue RE Experience with pandemic 2009 H1N1 influenza in a large pediatric hospital. South Med J 2012, 105:192-198.
38. Goodacre S, Challen K, Wilson R, Campbell M Evaluation of triage methods used to select patients with suspected pandemic influenza for hospital admission: cohort study. Health Technol Assess 2010, 14:173-236.
39. Hite LK, Glezen WP, Demmler GJ, Munoz FM Medically attended pediatric influenza during the resurgence of the Victoria lineage of influenza B virus. Int J Infect Dis 2007, 11:40-47.
40. Launes C, Garcia-Garcia JJ, Martinez-Planas A, et al. 2009 H1N1: risk factors for hospitalization in a matched case-control study. Eur J Pediatr 2012, 171:1127-1131.
41. Lee CY, Chuang YF, Huang WY, Cheng SH, Pei JS Epidemiology, clinical features, treatment, and outcomes of cases of influenza A infection during the 2009 influenza pandemic in northern Taiwan. Pediatr Neonatol 2012, 53:257-263.
42. Lee MC, Kim HY, Kong SG, et al. Clinical characteristics of pandemic influenza A (H1N1) 2009 pediatric infection in Busan and Gyeongsangnam-do: one institution. Tuberc Respir Dis (Seoul) 2012, 72:493-500.
43. Lenzi L, Mello ÂMd, Silva LRd, Grochocki MHC, Pontarolo R Manifestações clínicas, desfechos e fatores prognósticos da influenza pandêmica A (H1N1) de 2009 em crianças. Revista Paulista de Pediatria 2012, 30:346-352.
44. Lera E, Worner NT, Sancosmed M, et al. Clinical and epidemiological characteristics of patients with influenza A (H1N1) 2009 attended to at the emergency room of a children's hospital. Eur J Pediatr 2011, 170:371-378.
45. Matsuzaki Y, Katsushima N, Nagai Y, et al. Clinical features of influenza C virus infection in children. J Infect Dis 2006, 193:1229-1235.
46. Na S, Kim M-N, Kim WY, et al. Prevalence and clinical features of pneumonia in patients with laboratory-confirmed pandemic influenza A H1N1 2009 infection in South Korea. Scand J Infect Dis 2011, 43:19-26.
47. Peltola V, Ziegler T, Ruuskanen O Influenza A and B virus infections in children. Clin Infect Dis 2003, 36:299-305.
48. Perez-Padilla R, Fernandez R, Garcia-Sancho C, et al. Pandemic (H1N1) 2009 virus and Down syndrome patients. Emerg Infect Dis 2010, 16:1312-1314.
49. Plessa E, Diakakis P, Gardelis J, Thirios A, Koletsi P, Falagas ME Clinical features, risk factors, and complications among pediatric patients with pandemic influenza A (H1N1). Clin Pediatr 2010, 49:777-781.
50. Quach C, Piche-Walker L, Platt R, Moore D Risk factors associated with severe influenza infections in childhood: implication for vaccine strategy. Pediatrics 2003, 112:e197-e201.
51. Rabasco MAC, Capistros MT, Castan AR, Castellvi PS, Solas VP, Martinez-Roig A Clinical and epidemiological characteristics of children with 2009 influenza A (H1N1) infection. [Catalan]. Pediatria Catalana 2011, 71:91-95.
52. Rodriguez-Valero M, Prado Calleros HM, Bravo Escobar GA, et al. Difference between early clinical features of swine origin A H1N1 influenza confirmed and not confirmed infection in Mexico. J Infect Dev Ctries 2012, 6:302-310.
53. Sessa A, Costa B, Bamfi F, Bettoncelli G, D'Ambrosio G The incidence, natural history and associated outcomes of influenza-like illness and clinical influenza in Italy. Fam Pract 2001, 18:629-634.
54. Smit PM, Bongers KM, Kuiper RJL, von Rosenstiel IA, Smits PHM, Brandjes DPM Characterization of 2009 H1N1 pandemic influenza in a population of Dutch children with influenza-like signs and symptoms. Acta Paediatr 2012, 101:67-72.
55. Mistry RD, Fischer JB, Prasad PA, Coffin SE, Alpern ER Severe complications in influenza-like illnesses. Pediatrics 2014, 134:e684-e690.
56. Burton C, Vaudry W, Moore D, et al. Burden of seasonal influenza in children with neurodevelopmental conditions. Pediatr Infect Dis J 2014, 33:710-714.
57. Riley RD, Hayden JA, Steyerberg EW, et al. Prognosis Research Strategy (PROGRESS) 2: prognostic factor research. PLoS Med 2013, 10:e1001380.
58. Louie JK, Acosta M, Samuel MC, et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis 2011, 52:301-312.
59. Dharan NJ, Sokolow LZ, Cheng PY, et al. Child, household, and caregiver characteristics associated with hospitalization for influenza among children 6-59 months of gge: an Emerging Infections Program study. Pediatr Infect Dis J 2014, 33:e141-e150.
60. Chen K-F, Hsieh Y-H, Gaydos CA, Valsamakis A, Rothman RE Derivation of a clinical prediction rule to predict hospitalization for influenza in EDs. Am J Emerg Med 2013, 31:529-534.
61. Beck S, Wojdyla D, Say L, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 2010, 88:31-38.
62. Crump C, Sundquist K, Sundquist J, Winkleby MA Gestational age at birth and mortality in young adulthood. JAMA 2011, 306:1233-1240.
63. Department of Communicable Disease Surveillance and Response, Global Influenza Programme. WHO global influenza preparedness plan-the role of WHO and recommendations for national measures before and during pandemics WHO, (accessed Oct 13, 2014). http://www.who.int/csr/resources/publications/influenza/WHO_CDS_CSR_GIP_2005_5.pdf.
64. UK Influenza Pandemic Preparedness Strategy 2011 UK Department of Health, (accessed Oct 13, 2014). https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/213717/dh_131040.pdf.
65. Influenza vaccine uptake amongst GP patient groups in England, winter season 2012/13 Public Health England, (accessed Oct 13, 2014). https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/207134/Influenza_vaccine_uptake_amongst_GP_patient_groups_in_England_for_winter_season_2012_2013.pdf.
66. Rodgers L, Grohskpf L, Pabst LJ, Harris L, Chaves SS Uptake of live attenuated influenza vaccine among children in selected populations of the United States (accessed Sept 17, 2014). https://cste.confex.com/cste/2013/webprogram/Paper2149.html.
67. Lu PJ, Santibanez TA, Williams WW, et al. Surveillance of influenza vaccination coverage-United States, 2007-08 through 2011-12 influenza seasons. MMWR Surveill Summ 2013, 62:1-28.
68. Pebody RG, Green HK, Andrews N, et al. Uptake and impact of a new live attenuated influenza vaccine programme in England: early results of a pilot in primary school-age children, 2013/14 influenza season. Euro Surveill 2014, 19:20823.
69. Overarching government strategy to respond to an influenza pandemic-analysis of the scientific evidence base Civil Contingencies Secretariat, UK Cabinet OfficeUK Cabinet Office, (accessed Oct 13, 2014). https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/61968/flu_pandemic_science:paper1.pdf.
70. Lim WS Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Thorax 2007, 62:1-46.